Navigation Links
Sundia in Top 100 Fast-growth Outsourcing Companies in China
Date:7/20/2009

SHANGHAI, July 20 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, announced today that the company was named as a Top 100 Fast-growth Outsourcing Service Provider. This selection was jointly sponsored by China Council for International Investment Promotion (CCIIP) and three global leading market researchers, TPI, IDC and Gartner. This ranking covers outsourcing services in IT, pharmaceutical, biotech, and all industrial fields. The list was announced at the 2nd China International Outsourcing Service Cooperation Conference.

The Top 100 outsourcing ranking was determined based on company size and growth rate, business income, and per headcount revenue. As a leading pharmaceutical R&D CRO company, Sundia is consistently focused on providing high quality CRO services to pharmaceutical and biotech company clients worldwide. Since its founding in 2004, the company's CRO service business has been growing at a high rate. "We are very pleased and honored to be included in this list," Commented Dr. Xiaochuan Wang, Chairman and CEO of Sundia. "It is another recognition of the effort of all of our team members."

About Sundia MediTech

Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China. It was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from chemical services, medicinal chemistry, biological service, new technology platforms and services, and pharmaceutical development.


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Bioinformatics Expert Dr. Jiaan Yang Joins Sundia MediTech With Innovative PFSC Technology
2. Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
3. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
4. Sundias Animal Facility Passed Client and Government Inspection
5. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
6. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
7. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
8. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
9. 2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession
10. Process Analytical Technology (PAT): The Official Language of Pharmaceutical Outsourcing
11. Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... ... AMRI, a global contract research, development and manufacturing organization ... quality of life, will now be offering its impurity solutions as a stand-alone ... for all new drug products, including the finalization of ICH M7 earlier this ...
(Date:10/11/2017)... ... 2017 , ... Personal eye wash is a basic first aid supply for any work environment, ... eye do you rinse first if a dangerous substance enters both eyes? It’s one less ... with its unique dual eye piece. , “Whether its dirt and debris, or an acid ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building ... corporate rebranding initiative announced today. The bold new look is part of a ... company moves into a significant growth period. , It will also expand its service ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):